HOPA Now
HOPA Now
Podcast Description
Welcome to HOPA Now, a podcast from the Hematology/Oncology Pharmacy Association. Join hosts Benjamin Andrick, PharmD, BCOP and Matt Mueller as they interview guests in the Hem/Onc pharmacy world to provide insight into the topics that Hematology/Oncology pharmacists and cancer patients are talking about.
Interested in contributing to a future episode? Got a topic suggestion? We'd love to hear from you.
Email us at [email protected]
Podcast Insights
Content Themes
The podcast primarily focuses on topics relevant to Hem/Onc pharmacy professionals and cancer patients, with episodes addressing issues such as improving diverse representation in cancer clinical trials and enhancing safety and accessibility in clinical trials. Specific episodes feature discussions on AI applications in healthcare and institutional patient care efforts.
Welcome to HOPA Now, a podcast from the Hematology/Oncology Pharmacy Association. Join hosts Peter Stuessy, PharmD, BCOP and Matt Mueller as they interview guests in the Hem/Onc pharmacy world to provide insight into the topics that Hematology/Oncology pharmacists and cancer patients are talking about.
Interested in contributing to a future episode? Got a topic suggestion? We’d love to hear from you.
Email us at [email protected]
Daraxonrasib is a drug that needs little introduction – it's the potential breakthrough in pancreatic cancer therapy that everyone’s been talking about for the past few weeks. It’s a total gamechanger in the fight against one of the deadliest, most aggressive cancers.
What are the findings from the RASolute 302 trial? What does its recent FDA approval mean for pancreatic cancer therapy? And how does it impact your patients? HOPA members Courtney Cavalieri and Benjamin Andrick sat down to discuss everything you need to know.
Check out Courtney's article on the drug in the latest issue of HOPA News.
Find out more about Daraxonrasib in HOPA's Late-Breaking News article by Michael Arnold: https://www.hoparx.org/latest-news/late-breaking-hopa-news-rasolute-302-breakthrough-in-metastatic-pancreatic-adenocarcinoma/
Interested in contributing to a future episode? Got a topic suggestion? We'd love to hear from you. Email us at [email protected]
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.